Novel pMDI formulations for pulmonary delivery of proteins

被引:40
|
作者
Li, Hao-Ying [1 ]
Seville, Peter C. [1 ]
机构
[1] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England
基金
英国工程与自然科学研究理事会;
关键词
Sodium carboxymethylcellulose; HFA-134a; pMDI; Protein; Spray-drying; SPRAY-DRIED POWDERS; AEROSOLISATION PROPERTIES; STABILITY; TETRAFLUOROETHANE; PERFORMANCE; PARTICLES; CELLULOSE; POLYMERS; AEROSOLS; RELEASE;
D O I
10.1016/j.ijpharm.2009.10.032
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this paper, we demonstrate that co-spray-drying a model protein with sodium carboxymethylcellulose (NaCMC) protects protein integrity during spray-drying, and that the resultant spray-dried powders can be successfully dispersed in hydrofluoroalkane (HFA) propellant to prepare pressurised metered dose (pMDI) formulations that exhibit high respirable fractions. The spray-dried powders were formulated as HFA-134a pMDI suspensions in the absence of any other excipients (e.g. surfactants) or co-solvents (e.g ethanol). The in vitro aerosolisation profile of these systems was assessed using the twin stage impinger, fine particle fractions (FPF) >= 50% of the recovered dose were obtained. Following storage for five months, the aerosolisation performance was reassessed; the NaCMC-free formulation demonstrated a significant decrease in FPF, whereas the performance of the NaCMC-modified formulations was statistically equivalent to their initial performance. Thus, formulation of pMDI suspensions using NaCMC-based spray-dried powders is a promising approach for the pulmonary delivery of proteins and peptides. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:73 / 78
页数:6
相关论文
共 50 条
  • [1] Innovative pMDI formulations of spray-dried nanoparticles for efficient pulmonary drug delivery
    Li, Hao-Ying
    Xu, En-Yu
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 530 (1-2) : 12 - 20
  • [2] Pressurised metered dose inhaler formulations for pulmonary delivery of proteins
    Li, H. Y.
    Seville, P. C.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 : A33 - A33
  • [3] Formulations for delivery of therapeutic proteins
    Snjezana Stolnik
    Kevin Shakesheff
    Biotechnology Letters, 2009, 31 : 1 - 11
  • [4] Formulations for delivery of therapeutic proteins
    Stolnik, Snjezana
    Shakesheff, Kevin
    BIOTECHNOLOGY LETTERS, 2009, 31 (01) : 1 - 11
  • [5] Novel approaches to enhance pulmonary delivery of proteins and peptides
    Scheuch, G.
    Siekmeier, R.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2007, 58 : 615 - 625
  • [6] Nanoparticle Formulations in Pulmonary Drug Delivery
    Bailey, Mark M.
    Berkland, Cory J.
    MEDICINAL RESEARCH REVIEWS, 2009, 29 (01) : 196 - 212
  • [7] Design optimization of a novel pMDI actuator for systemic drug delivery
    Kakade, Prashant P.
    Versteeg, Henk K.
    Hargrave, Graham K.
    Genova, Perry
    Williams, Robert C., III
    Deaton, Daniel
    JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2007, 20 (04): : 460 - 474
  • [8] Dry powder formulations for pulmonary delivery
    Malcolmson, RJ
    Embleton, JK
    PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1998, 1 (09): : 394 - 398
  • [9] INVESTIGATIONS OF TIOTROPIUM pMDI SUSPENSION FORMULATIONS
    Tran, Cuong Hoa
    Zheng, Chen
    Warren, Simon
    Taylor, Glyn
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2014, 27 (04) : A10 - A10
  • [10] Controlled release formulations for pulmonary drug delivery
    Learoyd, T. P.
    Burrow, J. L.
    French, E.
    Seville, P. C.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 : A70 - A70